Evidence map›Paper›PMID 41675691›Full record

ArticleFrontiers in neuroscience2025

Dimensionality reduction of quantitative EEG and clinical profiles uncover associations with monogenic neurodevelopmental phenotypes in SNAREopathies.

Additya Sharma, Shilpa Anand, Cece C Kooper, Michel J A M van Putten, Arthur-Ervin Avramiea, Marina Diachenko, Arianne Bouman, Winde Mercken, Jennifer R Ramautar, Huibert D Mansvelder and 4 more

Abstract read
In one paragraph

Article in Frontiers in neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Additya Sharma *Department of Integrative Neurophysiology, Centre for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Shilpa Anand *Department of Child and Adolescent Psychiatry and Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (UMC), Amsterdam, Netherlands.
Cece C KooperEmma Neuroscience Group, Department of Paediatrics, Emma Children's Hospital, Amsterdam Universtiet Medische Centrum (UMC), University of Amsterdam, Amsterdam, Netherlands.
Michel J A M van PuttenDepartment of Clinical Neurophysiology, Medisch Spectrum Twente, Enschede, Netherlands.
Arthur-Ervin AvramieaDepartment of Integrative Neurophysiology, Centre for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Marina DiachenkoDepartment of Integrative Neurophysiology, Centre for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Arianne BoumanDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Winde MerckenDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Jennifer R RamautarDepartment of Child and Adolescent Psychiatry and Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (UMC), Amsterdam, Netherlands.
Huibert D MansvelderDepartment of Integrative Neurophysiology, Centre for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.
Mathijs VerhageN=You Neurodevelopmental Precision Center, Amsterdam Neuroscience, Amsterdam Reproduction and Development, Amsterdam UMC, Amsterdam, Netherlands.
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Hilgo BruiningDepartment of Child and Adolescent Psychiatry and Psychosocial Care, Emma Children's Hospital, Amsterdam University Medical Centre (UMC), Amsterdam, Netherlands.
Klaus Linkenkaer-HansenDepartment of Integrative Neurophysiology, Centre for Neurogenomics and Cognitive Research (CNCR), Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Monogenic neurodevelopmental disorders (mNDDs) such as SNAREopathies exhibit complex electrophysiological features and diversity among clinical symptoms, complicating the mapping of electro-clinical relationships, essential for improving diagnosis and treatment monitoring. Establishing robust normative electrophysiological feature distributions from typically developing populations enables precise, individualized quantification of patient-specific abnormalities. Here, we introduce a multivariate framework to reveal patient-specific electrophysiological phenotypes and clinical severity dimensions of direct relevance for individual prognosis and therapeutic tracking. Methods: We analyzed resting-state electroencephalography (EEG) data from15 SNAREopathy subjects ( Results: The normative qEEG space identified diffuse, spectro-spatial patterns for absolute power, while relative power and LRTC displayed frequency-specific distributions. Clinical PCA identified a primary dimension of clinical impairment integrating deficits in mobility, hand function, communication, and adaptive behavior, whereas the secondary component captured the severity of qualitative EEG abnormalities. Patient deviations from normative absolute and relative power correlated with the primary, while LRTC deviations aligned with the secondary severity component. Discussion: Normative qEEG deviance metrics correspond to distinct clinical severity dimensions in SNAREopathies, making them promising for tracking disorder progression and therapeutic response.

Indexed as

dimensionality reductionneurodevelopmentqualitative EEGquantitative EEGSNAREopathies

Identifiers

PMID41675691
PMCPMC12886349

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.